Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 13 | 2025 | 302 | 2.510 |
Why?
|
| Fatty Liver | 5 | 2024 | 77 | 1.560 |
Why?
|
| Myocytes, Cardiac | 4 | 2020 | 183 | 1.320 |
Why?
|
| Oxidative Stress | 12 | 2024 | 1003 | 1.290 |
Why?
|
| Apoptosis | 9 | 2020 | 1568 | 1.210 |
Why?
|
| Mice, Obese | 3 | 2020 | 42 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 1869 | 0.870 |
Why?
|
| Cotinine | 3 | 2020 | 44 | 0.790 |
Why?
|
| Heart | 2 | 2020 | 184 | 0.670 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2025 | 68 | 0.590 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 192 | 0.580 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 67 | 0.570 |
Why?
|
| Myocardium | 1 | 2020 | 263 | 0.560 |
Why?
|
| Muscle, Skeletal | 5 | 2025 | 316 | 0.550 |
Why?
|
| Mice | 18 | 2025 | 6644 | 0.550 |
Why?
|
| Benzamides | 1 | 2018 | 81 | 0.530 |
Why?
|
| Animals | 25 | 2025 | 16992 | 0.480 |
Why?
|
| Mitochondria | 5 | 2016 | 523 | 0.470 |
Why?
|
| Smoking | 2 | 2020 | 1024 | 0.470 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2014 | 70 | 0.430 |
Why?
|
| Spermatozoa | 3 | 2012 | 214 | 0.410 |
Why?
|
| Male | 21 | 2025 | 23409 | 0.360 |
Why?
|
| Minocycline | 1 | 2011 | 6 | 0.350 |
Why?
|
| Maternal Exposure | 1 | 2011 | 57 | 0.330 |
Why?
|
| Down-Regulation | 1 | 2011 | 456 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 96 | 0.290 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 88 | 0.280 |
Why?
|
| Cocaine | 1 | 2011 | 251 | 0.280 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2020 | 41 | 0.270 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 934 | 0.260 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2020 | 160 | 0.260 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 196 | 0.250 |
Why?
|
| Chromogranin A | 2 | 2016 | 7 | 0.250 |
Why?
|
| Obesity | 3 | 2025 | 1151 | 0.240 |
Why?
|
| Mice, Knockout | 6 | 2019 | 1035 | 0.230 |
Why?
|
| Niacinamide | 1 | 2024 | 16 | 0.210 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 29 | 0.210 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 830 | 0.200 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 1596 | 0.200 |
Why?
|
| Endoribonucleases | 1 | 2023 | 25 | 0.190 |
Why?
|
| Triglycerides | 2 | 2014 | 147 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2016 | 986 | 0.190 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 161 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 161 | 0.180 |
Why?
|
| Pregnancy | 2 | 2020 | 1772 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 40 | 0.170 |
Why?
|
| Lipolysis | 2 | 2023 | 20 | 0.160 |
Why?
|
| Models, Biological | 2 | 2016 | 712 | 0.160 |
Why?
|
| Echocardiography | 1 | 2020 | 167 | 0.150 |
Why?
|
| Pyrazines | 2 | 2023 | 32 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2020 | 352 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2020 | 123 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2019 | 883 | 0.150 |
Why?
|
| Aerosols | 1 | 2019 | 54 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 59 | 0.150 |
Why?
|
| Life Style | 1 | 2021 | 334 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2018 | 2157 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 147 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2012 | 638 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2019 | 122 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 114 | 0.140 |
Why?
|
| Caspases | 2 | 2016 | 148 | 0.140 |
Why?
|
| Spermatogenesis | 2 | 2011 | 161 | 0.140 |
Why?
|
| Analysis of Variance | 1 | 2019 | 575 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2019 | 169 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 36 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 34 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2019 | 373 | 0.120 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 33 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1766 | 0.120 |
Why?
|
| Chromaffin Granules | 1 | 2015 | 1 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 2 | 2015 | 108 | 0.120 |
Why?
|
| Liver | 2 | 2024 | 511 | 0.120 |
Why?
|
| Catecholamines | 1 | 2015 | 45 | 0.120 |
Why?
|
| Hepatocytes | 2 | 2012 | 80 | 0.110 |
Why?
|
| Diet | 1 | 2021 | 826 | 0.110 |
Why?
|
| Body Weight | 2 | 2014 | 429 | 0.110 |
Why?
|
| Risk Factors | 2 | 2014 | 3994 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 201 | 0.110 |
Why?
|
| Parabiosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2015 | 187 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 12 | 0.100 |
Why?
|
| Muscle Development | 1 | 2014 | 51 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2011 | 117 | 0.100 |
Why?
|
| Enzyme Activation | 3 | 2012 | 462 | 0.100 |
Why?
|
| Rats | 3 | 2011 | 3735 | 0.100 |
Why?
|
| Cystine | 1 | 2013 | 14 | 0.100 |
Why?
|
| Testosterone | 1 | 2014 | 211 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2013 | 15 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 27 | 0.100 |
Why?
|
| Animal Feed | 1 | 2012 | 53 | 0.090 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2012 | 2 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 182 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2011 | 152 | 0.090 |
Why?
|
| Testis | 2 | 2012 | 207 | 0.090 |
Why?
|
| beta Catenin | 1 | 2011 | 78 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 64 | 0.080 |
Why?
|
| Body Composition | 1 | 2011 | 159 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2011 | 57 | 0.080 |
Why?
|
| Sertoli Cells | 2 | 2011 | 43 | 0.080 |
Why?
|
| Humans | 7 | 2023 | 43102 | 0.080 |
Why?
|
| Antioxidants | 1 | 2013 | 443 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 12 | 0.070 |
Why?
|
| Fever | 1 | 2008 | 62 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 137 | 0.070 |
Why?
|
| Imidazoles | 1 | 2008 | 142 | 0.070 |
Why?
|
| Pyridines | 1 | 2008 | 139 | 0.070 |
Why?
|
| Female | 3 | 2020 | 24698 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 783 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 458 | 0.060 |
Why?
|
| WT1 Proteins | 1 | 2006 | 4 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2012 | 518 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 20 | 0.060 |
Why?
|
| Germ Cells | 1 | 2006 | 74 | 0.060 |
Why?
|
| Apolipoproteins E | 2 | 2019 | 138 | 0.060 |
Why?
|
| RNA Interference | 1 | 2006 | 247 | 0.060 |
Why?
|
| Glucose | 2 | 2016 | 244 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2016 | 105 | 0.050 |
Why?
|
| Palmitates | 1 | 2023 | 15 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 63 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2023 | 134 | 0.050 |
Why?
|
| Meiosis | 2 | 2012 | 67 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 780 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 678 | 0.040 |
Why?
|
| Ribonuclease III | 2 | 2012 | 10 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 44 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 1177 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2011 | 210 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 191 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 41 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 71 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 532 | 0.030 |
Why?
|
| Splanchnic Nerves | 1 | 2015 | 2 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 27 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 36 | 0.030 |
Why?
|
| Glycogen | 1 | 2015 | 20 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2015 | 18 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 31 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 97 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 49 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 118 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 299 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 34 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2014 | 38 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 170 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 275 | 0.030 |
Why?
|
| Insulin | 1 | 2015 | 258 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 84 | 0.020 |
Why?
|
| Sperm Head | 1 | 2012 | 10 | 0.020 |
Why?
|
| Haploidy | 1 | 2012 | 16 | 0.020 |
Why?
|
| Protamines | 1 | 2012 | 21 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 35 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 57 | 0.020 |
Why?
|
| Reproduction | 1 | 2012 | 94 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 19 | 0.020 |
Why?
|
| Selenomethionine | 1 | 2011 | 13 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 132 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 32 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 76 | 0.020 |
Why?
|
| Energy Intake | 1 | 2011 | 164 | 0.020 |
Why?
|
| Hela Cells | 1 | 2012 | 376 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 310 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 238 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 234 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 186 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 157 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 652 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 983 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 704 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1271 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.020 |
Why?
|
| DNA Polymerase II | 1 | 2006 | 5 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2006 | 11 | 0.020 |
Why?
|
| Gonads | 1 | 2006 | 21 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 7 | 0.010 |
Why?
|
| RNA Precursors | 1 | 2006 | 28 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2005 | 30 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 141 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2005 | 107 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 227 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 532 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 665 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 701 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 945 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2006 | 735 | 0.010 |
Why?
|